250 related articles for article (PubMed ID: 32387663)
1. Field cancerization: Treatment.
Cornejo CM; Jambusaria-Pahlajani A; Willenbrink TJ; Schmults CD; Arron ST; Ruiz ES
J Am Acad Dermatol; 2020 Sep; 83(3):719-730. PubMed ID: 32387663
[TBL] [Abstract][Full Text] [Related]
2. Actinic Keratoses: Reconciling the Biology of Field Cancerization with Treatment Paradigms.
Gilchrest BA
J Invest Dermatol; 2021 Apr; 141(4):727-731. PubMed ID: 32956650
[TBL] [Abstract][Full Text] [Related]
3. Field cancerization: Definition, epidemiology, risk factors, and outcomes.
Willenbrink TJ; Ruiz ES; Cornejo CM; Schmults CD; Arron ST; Jambusaria-Pahlajani A
J Am Acad Dermatol; 2020 Sep; 83(3):709-717. PubMed ID: 32387665
[TBL] [Abstract][Full Text] [Related]
4. Cryosurgery combined with topical interventions for actinic keratosis: a systematic review and meta-analysis.
Heppt MV; Steeb T; Ruzicka T; Berking C
Br J Dermatol; 2019 Apr; 180(4):740-748. PubMed ID: 30447074
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative photodynamic therapy: a description of a new adjuvant technique for patients with nonmelanoma skin cancer.
Marmur ES; Nolan KA; Henry M
Dermatol Surg; 2012 Jul; 38(7 Pt 1):1073-6. PubMed ID: 22607107
[No Abstract] [Full Text] [Related]
6. European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes).
Kandolf L; Peris K; Malvehy J; Mosterd K; Heppt MV; Fargnoli MC; Berking C; Arenberger P; Bylaite-Bučinskiene M; Del Marmol V; Dirschka T; Dreno B; Forsea AM; Harwood CA; Hauschild A; Heerfordt IM; Kauffman R; Kelleners-Smeets N; Lallas A; Lebbe C; Leiter U; Longo C; Mijušković Ž; Pellacani G; Puig S; Saiag P; Šitum M; Stockfleth E; Salavastru C; Stratigos A; Zalaudek I; Garbe C;
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):1024-1047. PubMed ID: 38451047
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy.
Patel P; Wang J; Bitterman D; Mineroff J; Austin E; Jagdeo J
Arch Dermatol Res; 2024 Mar; 316(4):108. PubMed ID: 38498070
[TBL] [Abstract][Full Text] [Related]
8. [Topical therapy of squamous cell carcinoma].
Hengge UR
Hautarzt; 2007 May; 58(5):412-8. PubMed ID: 17429585
[TBL] [Abstract][Full Text] [Related]
9. Sequential Curettage, 5-Fluorouracil, and Photodynamic Therapy for Field Cancerization of the Scalp and Face in Solid Organ Transplant Recipients.
Jambusaria-Pahlajani A; Ortman S; Schmults CD; Liang C
Dermatol Surg; 2016 Jan; 42 Suppl 1():S66-72. PubMed ID: 26730976
[TBL] [Abstract][Full Text] [Related]
10. Swiss clinical practice guidelines on field cancerization of the skin.
Hofbauer G; Anliker M; Boehncke WH; Brand C; Braun R; Gaide O; Hafner J; Hunger R; Itin P; Kaeuper G; Lautenschlager S; Mainetti C; Streit M
Swiss Med Wkly; 2014; 144():w14026. PubMed ID: 25539459
[TBL] [Abstract][Full Text] [Related]
11. [Actinic keratoses].
Hommel T; Szeimies RM
Hautarzt; 2016 Nov; 67(11):867-875. PubMed ID: 27613022
[TBL] [Abstract][Full Text] [Related]
12. Case-based considerations in the treatment of actinic keratoses: utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments.
Han A; Penrose C; Goldsmith A; Marmur ES
J Drugs Dermatol; 2010 Jul; 9(7):864-9. PubMed ID: 20677546
[TBL] [Abstract][Full Text] [Related]
13. [Beyond actinic keratoses: Field cancerization of the skin].
Reygagne P; Rostain G
Ann Dermatol Venereol; 2018 Oct; 145(10):587-592. PubMed ID: 30243819
[TBL] [Abstract][Full Text] [Related]
14. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
Yoon J; Phibbs CS; Chow A; Weinstock MA;
J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
[TBL] [Abstract][Full Text] [Related]
15. Keratinocyte cancer and its precursors in organ transplant patients.
Jenni D; Hofbauer GF
Curr Probl Dermatol; 2015; 46():49-57. PubMed ID: 25561206
[TBL] [Abstract][Full Text] [Related]
16. Actinic keratoses: past, present and future.
Fenske NA; Spencer J; Adam F
J Drugs Dermatol; 2010 May; 9(5 Suppl ODAC Conf Pt 1):s45-9. PubMed ID: 20518359
[TBL] [Abstract][Full Text] [Related]
17. Topical treatments for skin cancer.
Cullen JK; Simmons JL; Parsons PG; Boyle GM
Adv Drug Deliv Rev; 2020 Jan; 153():54-64. PubMed ID: 31705912
[TBL] [Abstract][Full Text] [Related]
18. Actinic keratosis and squamous cell carcinoma: clinical and pathological features.
Filosa A; Filosa G
G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352
[TBL] [Abstract][Full Text] [Related]
19. Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
Terushkin V; Braga JC; Dusza SW; Scope A; Busam K; Marghoob AA; Gill M; Halpern AC
Dermatol Surg; 2010 Oct; 36(10):1514-20. PubMed ID: 20698872
[TBL] [Abstract][Full Text] [Related]
20. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
Philipp-Dormston WG
Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
